CLINICAL_TRIALS
trial_result
· 2020-12-02
Clinical Trial Update: Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax [Phase 2]
Summary
Phase 2 trial evaluating combination immunotherapy with Herceptin and the HER2 vaccine NeuVax in breast cancer has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: George E. Peoples | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-12-02